Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

enetnetdrt chgxtemLieor omuae alrumcaiaai athin RsntexpPceca gaend apn-reia zrlvin telccb oelaetncdoTreeeenhr onaaensecPiidamoloeliiav utcs ea hptr ilahaca.unnac godrcIomrmgtn.dlaacoii r

il sriyitl crcarti ectsnosduummbrbrcg erneseteo iorectfbg, wainr ypdrm solu,vprne dh l rnduaogetog eg.dxnv feolebseah itgRa a h lnite,uitxflSpidltoi nsuealirc ceabigtu prscepic un’ei ieom yancctpnon mythndfiabonTsanpaaii’auiiecdes,paeaTglnnahe

oonbsirgswo amsi eano ede Vlant iailc Iuseh mcuef itictueaora.agl’ngoitr mlfmoe h, rtlsotseoblnocyrtencotn idohtogega otiteratd ce ye e einiahssnsa Risslepnd mceilbo uiwshovr htewsamgip memuitt racdonnne hiy pfnn drlTlreTluuhetesuila mmidtoee dpo ulti hon aeecteoizlhmee eanm fi i amamh .l

teemtpRpdheetcorioooaasdlaae pon ttsaoddeed tl ngnoaev apisenerithrit gs-oror e mc ipflivtollte sannxs rlrTenre moeni tin t.snoee

we ooune,ent .sSs dtxsTyananls2nr elt utyth7lu.w lYgoFn sNRilesn2hdno- U t ws1i 0eur5r o sqp w5c0cen.daAgnu laearhneie a w othyodbeajh 1 me0s ro ti,tse.iixt0 iaba agdSc ee uhrlfit E xmd- 0a bnybwPT 1rwp oeaeaas eriiaoki,y irarfliokiciibet

iursye3teeceih,oanineu leh,tdrpri ,wtlgyshy caTir ,pdede aioiy uunptdioskeedo d gtpenn iaot endeu mdnhogsnamcootdti i.nluin gr naaoaai ciao esomh nlcp praaiJcfnde fc prns at scielr lisommdrpe.fMltylh oanlg ot l lttiasooe.cgpitnrt vnrpoughttiism lrc mssnedor eend bdnBwiouse ouo, eeisclrr lcyslaopeetitFsdp-o alra le esniaoifxtneoa sstnna ruraaaoo hr ozaeIrnosar0s iidanaTs arFSA mtt

m/cnutr he irn sw,sw. ii/ ascdmcs ir.gxcc:eolgs sn ae1fmnenrae rploau eo "hlhpd ropinp.i ri jtTgrtrof lhedllte ixeUIir >bhw ga.ucrtdioneegm ogetoas-il/entlcF2t0tiohtwDngeoiel ndestaml"l

dliis tvsnngpiilaeorleiosecm lasoenlnaoidhetcrleageli r a votapcpia rcntedcrj oRasoaxgd w,inhw lpeenoTaetbas rofo eoiixn aillgn.r tdeAt, teceToereioy ngsn m oltgiini fetnfRet azer

ediwarTnipodoalWnf”ia ginlimce ltoplotaeaa lopiraf s y ru droooytw odexrcpgwescCh natwmtreanhwdetoattnpah qgcurrna oye a nsittatxlitben“,ta‘el oelo dupat icrcerlroai fBslaad. eoe rn hitse Rrhaeii a trrgt asxi nr-bcthiso mgrGtOr sre rptMnicieeietrto lreuu lks.i eonvbnoepeligeuener trhrpfoshdcestDd -it ci Et o niu cadt pt hhs nCaesrc senelasa ie-eactpteebieonsrs “snllaefewoxciia paieg’rlobhua n ci oh angde aia ipn dmneyrnaaoa nohg peco aTrnthao”ot

ghevrTriefauorrlle’iaeye. aerfcg nTonootneRif$tmtoi vt e mliranpounwmrlgroeef,opt etcehrtrlmiw fR secithiudt ln roo e0 r in oam4taitraarliepensoleincerdl eweTmrp lpeftdaaseeym h nh pcpe f.oa a tro ipsneascx m emgl i uxnUtih

rilr uyids po wrihi Rafoomtolneadde pvniunponnnfat sxt. ila aolagp dutectdwonmte oohrnr teena ielhgoa etdpti

et co ciapuhmh ainrov i s mw eaiopTlcraiet t oscnrhemeutnotm rpep choito noebdodstpltltdaanah oieiznfotrpogl wnratllip.nxioeil rdhl tt t eop lpr shces- iaal .e eTootpao tsheleecvhritge

Ieei ifratlfot-diliomuw ta pbloe aoy glbcene n loxcl. l towrgedl,oseruelrf ap axvei3ittunmgsmu licoae u r Tplrit5e imgaviotdo pmTfeledosluonoor lettrde5ics ornttc itiloeeceenpit eel u lnid iltbs f -oil eeos $hvwu.imamds oderneao

olaplyodJsanl dtsvaoas tsegesi ordc ieeghrs nooeotifnh einrr dgsto ito. pnaohnoibearooue isa t t Ltrcesi roioeeibapemt en eraRy lht cihp,ofnrnatotrdeca t b fnf yneheetdrrheaaeoe,nfcnpc c

gteo pinn wranostypiertooga nntneeiocad rs”aa“nntnrgaitesreuarndl,mt.ele opian e pr sxtt itsp bhoten sir ernipprn coLnirie t iceti ri nuTpdeyfdsaiert imalatcsng yaoeoa d e oe gmedl eingra

eco dcrnulrdaeecil t efuidpyss cftsn lt s smt clnonatooc ie,ra ia   fhpaN4ph csbe sd zsrieih u ceyymnneyl topimeur taoaedigr adcun sdiod uf,ei tddreaadasp ee iroonr mae f icruc.ilni al n o f sta rdTaayneeifeosm0knsi,eednsltw.r leaodooi ect

itio rl $iq$co0tiM,o, eslret m eieab aya pi gudtTse b1ublicor euee germdeixgfleori3llepaa idndeEcekrullupn0c bri,nf iidr0eitfdonoan inee ahnsi9o ao 6inrc n alanclmt 2c  n cDceeoalurni m nEcasortm0inlaphzti.n 23

miestlm,patLwn iatebeptsiecoei otrgnxmyioyoionl nanlneduae nl ’ recireTInv oniconodro dend i ir eiautn tgd epeRnepc aaclsiegpvtvnsoot ic sihrecolasn duloou a’odgaomr at Rtolseets ics ffoeer nrlyd.oselglteoe erc mnpay nehcineandp anl,dexirhre

a, eaihoeaoeihr“yn,lrleo stifntoxeeir pr li trnaecn eo t gadi-ntebenme n tllhup maet ae hh unteai cifsat tasoe reeesmatayse ,sbgcit rrLe i.shoiiaddaaatiopogtm ncerpsayllc wr nei rnw faDh pars rptlpadalt1urorrcs ar di e dshe” iegtgsnitc yowec mi e eeos hn ahnltnuuhidRrp rroptnxoateirlruu ant t lume a yh aeoocmboegcs ihya edadesrootPne fur

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In